A federal court has preliminarily approved a proposed settlement in the consolidated shareholder derivative litigation regarding Abbott Laboratories' infant formula issues. This development marks a significant step toward resolving legal claims against the company's directors and officers, potentially reducing long-term legal uncertainty and liability for the firm.
